zr pharma& GmbH (“pharma&”) has partnered with Accelera Pharma Canada Inc. (“APCI”) as its exclusive distributor of PEGASYS® in Canada.
DESCRIPTION OF PEGASYS:
Peginterferon alfa-2a is a covalent conjugate of recombinant alfa-2a interferon (approximate molecular weight [MW] 20 kD) with a single branched bis-monomethoxy polyethylene glycol (PEG) chain (approximate MW 40 kD). Interferon alfa-2a is produced biosynthetically using recombinant DNA technology, and is the product of a cloned human leukocyte interferon gene inserted into and expressed in E. coli.
INDICATIONS AND CLINICAL USE
Chronic Hepatitis C (CHC)
PEGASYS (peginterferon alfa-2a) is indicated for the treatment of Chronic Hepatitis C in:
- Adult patients without cirrhosis
- Adult patients with compensated cirrhosis,
including HCV/HIV co-infection patients with stable HIV disease with or without antiretroviral therapy.
Chronic Hepatitis B (CHB)
PEGASYS is indicated for the treatment of both HBeAg-positive and HBeAg-negative chronic hepatitis B in:
- Patients with compensated liver disease, liver inflammation and evidence of viral replication (both cirrhotic and non-cirrhotic disease).
Geriatrics (> 65 years of age): Clinical studies of PEGASYS alone or in combination with COPEGUS did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects.
Pediatrics (< 18 years of age): PEGASYS is not authorized for use in children and adolescents under the age of 18 years (see WARNINGS AND PRECAUTIONS: Special Populations, Pediatrics).
Details of the Product codes are as follows:
PEGASYS® PFS 180 mcg/0.5 mL
| Product Description | Product Strength | DIN | APCI Product Code | UPC |
| PEGASYS® PFS 180 mcg/0.5 mL | 180 mcg | 02248077 | ARX-36582 | 0056090636582 |
Please contact the Accelera Pharma Canada Inc. (“APCI”) Customer Service Team to place your order at:
Toll Free: 1-855-611-2724 Ext 2202
e-FAX: 647-660-0279
Email: orders@apcipharma.com
For adverse events or product complaints, please call 1-855-611-2724
Cold chain products cannot be ordered with ambient product when placing orders with APCI.
Details of the Product codes are as follows:
PEGASYS® PFS 180 mcg/0.5 mL
| Product Description | PEGASYS® PFS 180 mcg/0.5 mL |
| Product Strength | 180 mcg |
| DIN | 02248077 |
| APCI Product code | ARX-36582 |
| UPC | 0056090636582 |
Please contact the Accelera Pharma Canada Inc. (“APCI”) Customer Service Team to place your order at:
Toll Free: 1-855-611-2724 Ext 2202
e-FAX: 647-660-0279
Email: orders@apcipharma.com
For adverse events or product complaints, please call 1-855-611-2724
Cold chain products cannot be ordered with ambient product when placing orders with APCI.